Keryx Shares Hit 18-Mo High As Zerenex Proves Well-Tolerated - Wall Street Journal PDF Print
Wall Street JournalThe drug, which treats high serum phosphorus levels in patients with end-stage renal disease on dialysis, had never been in a prior study longer than 28 ...Keryx Reports Results of Open Label Extension Study Examining Long ... PR Newswire (press release)Keryx Reports Positive Long-term Data For Kidney Drug Zerenex

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.